Valuation: Balaxi Pharmaceuticals Limited

Market Cap 865M 8.98M 7.85M 7.26M 6.66M 12.6M 12.82M 86.55M 34M 422M 33.72M 32.97M 1.46B P/E 2024
-214x
P/E 2025 14.1x
Enterprise Value 992M 10.3M 9M 8.32M 7.64M 14.46M 14.71M 99.28M 39M 485M 38.67M 37.82M 1.67B EV / Sales 2024
1.91x
EV / Sales 2025 1.16x
Free-Float
89.66%
Yield 2024 *
-
Yield 2025 -
1 day-1.12%
1 week-0.71%
Current month-0.33%
1 month+0.17%
3 months-4.49%
6 months-7.78%
Current year-11.31%
1 week 23.5
Extreme 23.5
24.75
1 month 22.5
Extreme 22.5
24.95
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
52.5
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 2017-05-03
Director of Finance/CFO - 2021-05-19
Compliance Officer - 2026-03-24
Director TitleAgeSince
Chairman 56 2017-05-03
Director/Board Member 54 -
Director/Board Member 44 2017-05-03
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%-0.71%-51.26%-76.61% 13.83M
+5.65%+2.77%+18.36%+105.45% 93.23B
+1.68%-3.55%+42.04%+145.57% 52.68B
+0.34%+5.00%+7.30%+281.82% 23.59B
+1.01%+5.45%-10.32%-19.20% 8.34B
+1.69%+10.47%-21.24%-28.77% 8.14B
+2.06%+3.67%-4.86%-24.05% 6.95B
+1.31%-3.90%+22.12%+31.99% 6.11B
+1.38%+2.55%+0.28%+24.31% 5.39B
+1.36%+4.39%-3.15%-3.62% 3.8B
Average +1.28%+1.47%-0.07%+43.69% 20.82B
Weighted average by Cap. +2.77%-1.13%+18.87%+114.76%

Financials

2024 2025
Net sales 2.41B 25.04M 21.89M 20.24M 18.58M 35.16M 35.77M 241M 94.83M 1.18B 94.04M 91.97M 4.07B 2.93B 30.36M 26.54M 24.54M 22.52M 42.62M 43.37M 293M 115M 1.43B 114M 112M 4.93B
Net income -23.87M -248K -217K -200K -184K -348K -354K -2.39M -938K -11.66M -930K -910K -40.24M 251M 2.6M 2.27M 2.1M 1.93M 3.65M 3.72M 25.08M 9.85M 122M 9.77M 9.56M 423M
Net Debt -432M -4.48M -3.92M -3.62M -3.32M -6.29M -6.4M -43.19M -16.97M -211M -16.82M -16.45M -728M 127M 1.32M 1.15M 1.07M 979K 1.85M 1.89M 12.73M 5M 62.13M 4.96M 4.85M 214M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
600
Date Price Change Volume
26-07-16 23.83 -1.12% 28,502
26-07-15 ₹24.10 -0.12% 9,948
26-07-14 ₹24.13 +0.37% 28,651
26-07-13 ₹24.04 -0.54% 11,826
26-07-10 ₹24.17 +0.62% 8,164
  1. Stock Market
  2. Stocks
  3. BALAXI Stock